LFMD
LifeMD, Inc.$4.10+0.01 (+0.21%)Prev Close$4.09·MCap$152.1M·P/E—·Vol407.7K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
9
$4.45M
◆
Net Activity
Net Seller
$4.45M
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at LifeMD, Inc. (LFMD) has been exclusively selling, with 0 insider purchases totaling $0.00 and 9 insider sales totaling $4.45M. The most recent insider transaction was by FRIEDEMAN JESSICA (Chief Marketing Officer), who sold $54.2K worth of shares on Dec 11, 2025. LifeMD, Inc. operates in the Healthcare sector, within the Medical - Pharmaceuticals industry, with a market cap of $152.1M.
LFMD Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | FRIEDEMAN JESSICA | Chief Marketing Officer | Sell | 15,000 | $3.61 | $54.2K | 205,000 |
| Aug 5, 2025 | Schreiber Justin | Chairman and CEO | Sell | 25,000 | $9.99 | $249.7K | 2,475,721 |
| Jul 3, 2025 | Schreiber Justin | Chairman and CEO | Sell | 25,000 | $13.38 | $334.5K | 2,500,721 |
| Jun 18, 2025 | Benathen Marc David | Chief Financial Officer | Sell | 125,000 | $13.46 | $1.68M | 389,554 |
| Jun 17, 2025 | Galluppi Stefan | Chief Innovation Officer | Sell | 85,000 | $12.38 | $1.05M | 80,449 |
| Jun 17, 2025 | Yecies Eric Harold | Chief Legal Officer & GC | Sell | 15,000 | $12.25 | $183.8K | 16,100 |
| Jun 4, 2025 | Schreiber Justin | Chairman and CEO | Sell | 25,000 | $12.47 | $311.7K | 2,525,721 |
| May 5, 2025 | Schreiber Justin | Chairman and CEO | Sell | 25,000 | $7.53 | $188.2K | 2,553,726 |
| May 1, 2025 | Schreiber Justin | Chairman and CEO | Sell | 50,000 | $7.78 | $389.0K | 2,575,721 |
| Mar 17, 2025 | FRIEDEMAN JESSICA | Chief Marketing Officer | Sell | 30,000 | $5.66 | $169.7K | 170,000 |
| Feb 21, 2025 | Schreiber Justin | Chief Executive Officer | Sell | 50,000 | $7.55 | $377.6K | 2,653,715 |
| Jan 6, 2025 | Schreiber Justin | Chief Executive Officer | Sell | 25,000 | $5.19 | $129.7K | 2,703,715 |
| Dec 4, 2024 | Schreiber Justin | Chief Executive Officer | Sell | 25,000 | $6.52 | $162.9K | 2,728,715 |
| Sep 12, 2024 | Galluppi Stefan | Chief Innovation Officer | Buy | 3,000 | $4.93 | $14.8K | 45,449 |
| Aug 31, 2023 | Velge Bertrand | Director | Buy | 132,072 | $3.79 | $501.0K | 349,482 |
| Jun 15, 2023 | Alvarez Nicholas P | Chief Acquisition Officer | Buy | 10,712 | $2.92 | $31.3K | 180,000 |
| Jun 15, 2023 | Velge Bertrand | Director | Buy | 3,945 | $2.94 | $11.6K | 212,310 |
| Jun 14, 2023 | Velge Bertrand | Director | Buy | 68,865 | $2.48 | $170.5K | 208,365 |
| Jun 14, 2023 | Yecies Eric Harold | General Counsel & CCO | Buy | 11,500 | $2.60 | $29.9K | 62,500 |
| Jun 7, 2023 | Velge Bertrand | Director | Buy | 139,500 | $2.18 | $303.9K | 139,500 |
| May 30, 2023 | Roberts Brad Michael | Chief Operating Officer | Buy | 30,000 | $2.19 | $65.7K | 97,632 |
| May 24, 2023 | Schreiber Justin | CEO | Buy | 50,000 | $2.09 | $104.6K | 2,844,620 |
| May 23, 2023 | Galluppi Stefan | Chief Innovation Officer | Buy | 10,000 | $2.17 | $21.7K | 17,841 |
| May 19, 2022 | BHATIA NAVEEN | Director | Buy | 50,000 | $2.14 | $106.8K | 246,349 |
| Mar 15, 2022 | Yecies Eric Harold | General Counsel & CCO | Buy | 5,000 | $3.14 | $15.7K | 51,000 |
| Mar 11, 2022 | DiTrolio Joseph | Director | Buy | 2,000 | $3.28 | $6.6K | 24,500 |
| Dec 8, 2021 | Velge Bertrand | Director | Buy | 25,000 | $4.54 | $113.5K | 916,666 |
| Dec 7, 2021 | Velge Bertrand | Director | Buy | 110,000 | $3.91 | $430.1K | 891,666 |
| Dec 1, 2021 | Benathen Marc David | Chief Financial Officer | Buy | 7,831 | $4.09 | $32.0K | 27,554 |
| Dec 1, 2021 | BHATIA NAVEEN | Director | Buy | 50,000 | $4.26 | $213.2K | 196,349 |
| Nov 30, 2021 | BHATIA NAVEEN | Director | Buy | 50,000 | $3.88 | $193.8K | 146,349 |
| Nov 23, 2021 | Yecies Eric Harold | CCO and General Counsel | Buy | 7,400 | $4.12 | $30.5K | 23,500 |
| Nov 22, 2021 | DiTrolio Joseph | Director | Buy | 2,000 | $4.89 | $9.8K | 22,500 |
| Nov 18, 2021 | Galluppi Stefan | Chief Technology Officer | Buy | 1,848 | $4.80 | $8.9K | 7,841 |
| Nov 16, 2021 | Galluppi Stefan | Chief Technology Officer | Buy | 2,197 | $4.55 | $10.0K | 5,993 |
| Sep 15, 2021 | Walters Happy David | Buy | 41,697 | $7.19 | $299.7K | 2,148,956 | |
| Aug 25, 2021 | Deutsch Corey | Chief Business Officer | Buy | 6,400 | $7.69 | $49.2K | 123,569 |
| Aug 23, 2021 | Deutsch Corey | Chief Business Officer | Buy | 4,000 | $7.37 | $29.5K | 117,169 |
| Aug 19, 2021 | DiTrolio Joseph | Director | Buy | 2,000 | $6.78 | $13.6K | 20,500 |
| Aug 18, 2021 | Benathen Marc David | Chief Financial Officer | Buy | 3,067 | $7.27 | $22.3K | 19,723 |
| Aug 18, 2021 | Deutsch Corey | Chief Business Officer | Buy | 12,000 | $6.82 | $81.8K | 113,169 |
LFMD Insider Buying Activity
The following table shows recent insider purchases of LifeMD, Inc. (LFMD) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Galluppi Stefan | Chief Innovation Officer | Buy | 3,000 | $4.93 | $14.8K | 45,449 |
| Aug 31, 2023 | Velge Bertrand | Director | Buy | 132,072 | $3.79 | $501.0K | 349,482 |
| Jun 15, 2023 | Alvarez Nicholas P | Chief Acquisition Officer | Buy | 10,712 | $2.92 | $31.3K | 180,000 |
| Jun 15, 2023 | Velge Bertrand | Director | Buy | 3,945 | $2.94 | $11.6K | 212,310 |
| Jun 14, 2023 | Velge Bertrand | Director | Buy | 68,865 | $2.48 | $170.5K | 208,365 |
| Jun 14, 2023 | Yecies Eric Harold | General Counsel & CCO | Buy | 11,500 | $2.60 | $29.9K | 62,500 |
| Jun 7, 2023 | Velge Bertrand | Director | Buy | 139,500 | $2.18 | $303.9K | 139,500 |
| May 30, 2023 | Roberts Brad Michael | Chief Operating Officer | Buy | 30,000 | $2.19 | $65.7K | 97,632 |
| May 24, 2023 | Schreiber Justin | CEO | Buy | 50,000 | $2.09 | $104.6K | 2,844,620 |
| May 23, 2023 | Galluppi Stefan | Chief Innovation Officer | Buy | 10,000 | $2.17 | $21.7K | 17,841 |
| May 19, 2022 | BHATIA NAVEEN | Director | Buy | 50,000 | $2.14 | $106.8K | 246,349 |
| Mar 15, 2022 | Yecies Eric Harold | General Counsel & CCO | Buy | 5,000 | $3.14 | $15.7K | 51,000 |
| Mar 11, 2022 | DiTrolio Joseph | Director | Buy | 2,000 | $3.28 | $6.6K | 24,500 |
| Dec 8, 2021 | Velge Bertrand | Director | Buy | 25,000 | $4.54 | $113.5K | 916,666 |
| Dec 7, 2021 | Velge Bertrand | Director | Buy | 110,000 | $3.91 | $430.1K | 891,666 |
| Dec 1, 2021 | Benathen Marc David | Chief Financial Officer | Buy | 7,831 | $4.09 | $32.0K | 27,554 |
| Dec 1, 2021 | BHATIA NAVEEN | Director | Buy | 50,000 | $4.26 | $213.2K | 196,349 |
| Nov 30, 2021 | BHATIA NAVEEN | Director | Buy | 50,000 | $3.88 | $193.8K | 146,349 |
| Nov 23, 2021 | Yecies Eric Harold | CCO and General Counsel | Buy | 7,400 | $4.12 | $30.5K | 23,500 |
| Nov 22, 2021 | DiTrolio Joseph | Director | Buy | 2,000 | $4.89 | $9.8K | 22,500 |
| Nov 18, 2021 | Galluppi Stefan | Chief Technology Officer | Buy | 1,848 | $4.80 | $8.9K | 7,841 |
| Nov 16, 2021 | Galluppi Stefan | Chief Technology Officer | Buy | 2,197 | $4.55 | $10.0K | 5,993 |
| Sep 15, 2021 | Walters Happy David | Buy | 41,697 | $7.19 | $299.7K | 2,148,956 | |
| Aug 25, 2021 | Deutsch Corey | Chief Business Officer | Buy | 6,400 | $7.69 | $49.2K | 123,569 |
| Aug 23, 2021 | Deutsch Corey | Chief Business Officer | Buy | 4,000 | $7.37 | $29.5K | 117,169 |
| Aug 19, 2021 | DiTrolio Joseph | Director | Buy | 2,000 | $6.78 | $13.6K | 20,500 |
| Aug 18, 2021 | Benathen Marc David | Chief Financial Officer | Buy | 3,067 | $7.27 | $22.3K | 19,723 |
| Aug 18, 2021 | Deutsch Corey | Chief Business Officer | Buy | 12,000 | $6.82 | $81.8K | 113,169 |
LFMD Insider Selling Activity
The following table shows recent insider sales of LifeMD, Inc. (LFMD) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | FRIEDEMAN JESSICA | Chief Marketing Officer | Sell | 15,000 | $3.61 | $54.2K | 205,000 |
| Aug 5, 2025 | Schreiber Justin | Chairman and CEO | Sell | 25,000 | $9.99 | $249.7K | 2,475,721 |
| Jul 3, 2025 | Schreiber Justin | Chairman and CEO | Sell | 25,000 | $13.38 | $334.5K | 2,500,721 |
| Jun 18, 2025 | Benathen Marc David | Chief Financial Officer | Sell | 125,000 | $13.46 | $1.68M | 389,554 |
| Jun 17, 2025 | Galluppi Stefan | Chief Innovation Officer | Sell | 85,000 | $12.38 | $1.05M | 80,449 |
| Jun 17, 2025 | Yecies Eric Harold | Chief Legal Officer & GC | Sell | 15,000 | $12.25 | $183.8K | 16,100 |
| Jun 4, 2025 | Schreiber Justin | Chairman and CEO | Sell | 25,000 | $12.47 | $311.7K | 2,525,721 |
| May 5, 2025 | Schreiber Justin | Chairman and CEO | Sell | 25,000 | $7.53 | $188.2K | 2,553,726 |
| May 1, 2025 | Schreiber Justin | Chairman and CEO | Sell | 50,000 | $7.78 | $389.0K | 2,575,721 |
| Mar 17, 2025 | FRIEDEMAN JESSICA | Chief Marketing Officer | Sell | 30,000 | $5.66 | $169.7K | 170,000 |
| Feb 21, 2025 | Schreiber Justin | Chief Executive Officer | Sell | 50,000 | $7.55 | $377.6K | 2,653,715 |
| Jan 6, 2025 | Schreiber Justin | Chief Executive Officer | Sell | 25,000 | $5.19 | $129.7K | 2,703,715 |
| Dec 4, 2024 | Schreiber Justin | Chief Executive Officer | Sell | 25,000 | $6.52 | $162.9K | 2,728,715 |
LFMD Insiders
Similar Stocks to LFMD
LLY
Eli Lilly and Company
$918.63+0.12%
$921.90B
JNJ
Johnson & Johnson
$235.85-0.69%
$583.29B
ABBV
AbbVie Inc.
$206.49+0.19%
$398.49B
MRK
Merck & Co., Inc.
$114.38+0.16%
$286.57B
UNH
UnitedHealth Group Incorporated
$282.16+0.67%
$251.47B
AMGN
Amgen Inc.
$348.50-0.40%
$198.26B
ABT
Abbott Laboratories
$106.13-0.99%
$187.91B
GILD
Gilead Sciences, Inc.
$137.63-2.40%
$180.27B